Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Endometrial Neoplasms × enfortumab vedotin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Transitional Cell 8 Urinary Bladder Neoplasms 5 Ureteral Neoplasms 3 Muscle Invasive Bladder Urothelial Carcinoma 2 Carcinoma, Renal Cell 2 Advanced Bladder Cancer 2 Urogenital Neoplasms 1 Urachal adenocarcinoma 1 Salivary Gland Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Penile Squamous Cell Carcinoma (PSCC) 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Cancer 1 Melanoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma, Adenoid Cystic 1

Interventions

Paclitaxel 35 Carboplatin 28 pembrolizumab 22 Surveys and Questionnaires 20 Letrozole 14 Radiotherapy 13 Bevacizumab 13 Blood Specimen Collection 12 Metformin 11 Megestrol Acetate 11 olaparib 10 dostarlimab 10 Observation 9 Medroxyprogesterone Acetate 9 Indocyanine Green 9 Cisplatin 9 durvalumab 8 lenvatinib 7 Sentinel Lymph Node Biopsy 7 Radiation 7 Magnetic Resonance Spectroscopy 7 Lymph Node Excision 7 Early Intervention, Educational 7 atezolizumab 6 abemaciclib 6 Taxes 6 Specimen Handling 6 Methods 6 Hysterectomy 6 Everolimus 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07139977 2026-01-20

EV-4-EC

Medical College of Wisconsin

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡